Dr Bissan Al-Lazikani
Bissan Al-Lazikani FRSB MBCS is a data scientist and drug discoverer with experience in academia and industry. She is Professor, Genomic Medicine; Director of Discovery Data Science and founding faculty of the Data Science Institute at MD Anderson Cancer Center. Prior to this, she was Head of Data Science at the Institute of Cancer Research, London. […]
Dr Steven Niederer
Dr. Steven Niederer completed his undergraduate degree in Engineering Science at the University of Auckland in 2003 and his DPhil in Computer Science on modelling the rat heart at the University of Oxford in 2008. From 2010 to 2023 he started and grew the Cardiac Electro-Mechanics Research Group at King’s College London, where his research […]
Professor Petra Hamerlik
Petra Hamerlik is an accomplished researcher in primary pharmacology and brain cancer research. Her professional career has been a blend of academic and industry roles, including positions at the Danish Cancer Society, Cleveland Clinic, and AstraZeneca. In September 2022, Petra was recruited to the University of Manchester as the Inaugural Brain Tumour Charity Chair of […]
Professor Richard Gilbertson
Professor Richard J Gilbertson Professor Gilbertson trained as a paediatric oncologist in the UK before moving in 2000 to St Jude Children’s Research Hospital, USA where he served as Scientific and Comprehensive Cancer Centre Director, Executive Vice President and Lillian R Cannon Endowed Chair. In August 2015, he moved back home to England where he […]
Professor Paul Workman
Professor Paul Workman Paul Workman is Harrap Professor of Pharmacology and Therapeutics at The Institute of Cancer Research, London. He is renowned for his research on the discovery and mechanistic investigation of cancer drugs and chemical probes – including inhibitors of protein kinases, PI3 kinases, molecular chaperones including HSP90 and HSP70, and the Heat Shock […]
Dr Gary Newton
Dr Gary Newton Dr Gary Newton is a Team Leader at the Institute of Cancer Research. He is a member of the Centre for Cancer Drug Discovery where he applies his medicinal chemistry experience to validate new targets and develop effective medicines for the treatment of cancer. He has worked in biotech and contract research […]
Dr Manav Pathania
Manav received a BA in Biology from Grinnell College, in Iowa, and received his PhD in Cell Biology from Yale University, in Connecticut. At Yale he investigated microRNA control of postnatal neural stem cell differentiation and survival in Professor Angelique Bordey’s lab. His first postdoctoral appointment was in Professor Josef Kittler’s lab at UCL in […]
Professor Chris Jones
Professor Chris Jones Professor Chris Jones and his team concentrate on scanning the genome and epigenome of paediatric brain tumours. Their aim is to find the genes that are driving development of these cancers, and identifying ways to translate these findings into new treatments for children with these tumours. The team focuses on paediatric high […]
Dr Pau Creixell
Pau studied Human Biology at the Universitat Pompeu Fabra, Barcelona, before moving to Oxford, London and the Technical University of Denmark where he obtained his PhD in Computational Biology. He then received a postdoctoral fellowship from the Helen Hay Whitney Foundation to pursue his studies at the Koch Institute for Integrative Cancer Research at MIT. […]
Professor Louis Chesler
Professor Louis Chesler Professor Louis Chesler is working to discover and develop new drugs for children’s cancers that respond poorly to existing treatment. His research involves the three most common solid tumours of children – neuroblastoma, a nerve tumour, rhabdomyosarcoma, a muscle tumour, and medulloblastoma, a brain tumour. He leads the Paediatric Solid Tumour Biology and Therapeutics […]
